Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PREDICT Helps FDA Answer Appropriators' Call To Facilitate Imports

This article was originally published in The Tan Sheet

Executive Summary

The PREDICT information technology system should help FDA comply with the intent, if not the particulars, of a House Appropriations Committee suggestion to facilitate imports of goods that pose little risk.

You may also be interested in...



OTC Import Alerts Could Grow Due To PREDICT Requirements

PREDICT eventually will help low-risk importers because data will drive the system to not flag those firms, easing the import process. Firms should work hard to stay off the import alert list, which prompts closer scrutiny and can lead to delays.

OTC Import Alerts Could Grow Due To PREDICT Requirements

PREDICT eventually will help low-risk importers because data will drive the system to not flag those firms, easing the import process. Firms should work hard to stay off the import alert list, which prompts closer scrutiny and can lead to delays.

FDA Chief Operating Officer Brings IT Experience From CDC, Sodexo

Walter Harris, who also worked at the VA and HUD, will oversee FDA’s IT, budget, management and equal employment opportunity functions as head of the Office of Operations, one of four directorates that form a managerial layer between the Office of the Commissioner and the agency’s center directors.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel